Trial · NCT02407990
Results by group130
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 130
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Phase 1A: Number of Participants Experiencing Adverse Events (AEs) | BGB-A317 Phase 1A | 114 | Participants | ||
| Phase 1A: Number Of Participants With Abnormal Physical Examination Values | BGB-A317 Phase 1A | At least one postbaseline pulse rate measure ≤ 45 beats per minute (bpm) | 1 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Physical Examination Values | BGB-A317 Phase 1A | At least one postbaseline pulse rate measure ≥ 120 bpm | 6 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Physical Examination Values | BGB-A317 Phase 1A | At least one postbaseline SBP measure ≤ 60 millimeters of mercury (mmHg) | 0 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Physical Examination Values | BGB-A317 Phase 1A | At least one postbaseline SBP measure ≤ 90 mmHg | 9 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Physical Examination Values | BGB-A317 Phase 1A | At least one postbaseline SBP measure ≥ 160 mmHg | 17 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Physical Examination Values | BGB-A317 Phase 1A | At least one postbaseline DBP measure ≥ 100 mmHg | 5 | Participants | |
| Phase 1A: Number Of Participants Experiencing Dose-dependent Toxicity Through Ophthalmology Findings | BGB-A317 Phase 1A | 0 | Participants | ||
| Phase 1A: Number Of Participants With Abnormal Electrocardiograms | BGB-A317 Phase 1A | At least 1 postbaseline QT corrected using Fridericia's formula (QTcF) Interval measure of >450 msec | 31 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Electrocardiograms | BGB-A317 Phase 1A | At least 1 postbaseline QTcF Interval measure of > 480 msec | 9 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Electrocardiograms | BGB-A317 Phase 1A | At least 1 postbaseline QTcF Interval measure of > 500 msec | 3 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Electrocardiograms | BGB-A317 Phase 1A | At least 1 postbaseline QTcF Interval measure ≤ 30 msec increase from baseline | 73 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Electrocardiograms | BGB-A317 Phase 1A | At least 1 postbaseline QTcF Interval measure ≤ 30 and ≤ 60 msec increase from baseline | 35 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Electrocardiograms | BGB-A317 Phase 1A | At least 1 postbaseline QTcF Interval measure > 60 msec increase from baseline | 8 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Laboratory Values | BGB-A317 Phase 1A | Alanine Aminotransferase: High | 6 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Laboratory Values | BGB-A317 Phase 1A | Albumin: Low | 11 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Laboratory Values | BGB-A317 Phase 1A | Alkaline Phosphatase: High | 7 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Laboratory Values | BGB-A317 Phase 1A | Aspartate Aminotransferase: High | 5 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Laboratory Values | BGB-A317 Phase 1A | Bilirubin: High | 7 | Participants | |
| Phase 1A: Number Of Participants With Abnormal Laboratory Values | BGB-A317 Phase 1A | Calcium: Low | 7 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02407990/results